Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
PRME Prime Medicine
- 2.880
- -0.130-4.32%
Close Dec 13 16:00 ET
- 2.910
- +0.030+1.04%
Post 19:26 ET
377.74MMarket Cap-1.40P/E (TTM)
3.005High2.810Low1.17MVolume2.950Open3.010Pre Close3.37MTurnover1.83%Turnover RatioLossP/E (Static)131.16MShares9.80052wk High1.99P/B184.71MFloat Cap2.81052wk Low--Dividend TTM64.14MShs Float21.730Historical High--Div YieldTTM6.48%Amplitude2.810Historical Low2.865Avg Price1Lot Size
Prime Medicine Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 209K | 0 | 591K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --209K | --0 | --591K | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 5.79%54.44M | 23.01%55.67M | 22.23%48.93M | 64.14%191.29M | 40.99%54.54M | 62.57%51.46M | 72.05%45.26M | 101.19%40.03M | 37.96%116.54M | -35.60%38.69M |
| Selling and administrative expenses | 34.38%14.1M | 18.23%12.6M | 21.91%11.16M | 45.50%43.39M | 35.94%13.08M | 58.79%10.49M | 44.71%10.66M | 47.13%9.15M | 114.16%29.82M | 33.92%9.63M |
| -General and administrative expense | 34.38%14.1M | 18.23%12.6M | 21.91%11.16M | 45.50%43.39M | 35.94%13.08M | 58.79%10.49M | 44.71%10.66M | 47.13%9.15M | 114.16%29.82M | 33.92%9.63M |
| Research and development costs | -1.53%40.34M | 24.49%43.07M | 22.33%37.77M | 70.54%147.91M | 42.66%41.46M | 63.56%40.97M | 82.68%34.6M | 125.78%30.88M | 22.93%86.73M | -45.05%29.06M |
| Operating profit | -5.39%-54.23M | -23.01%-55.67M | -20.75%-48.34M | -64.14%-191.29M | -40.99%-54.54M | -62.57%-51.46M | -72.05%-45.26M | -101.19%-40.03M | -37.96%-116.54M | 35.60%-38.69M |
| Net non-operating interest income expense | 70.00%697K | -3.78%611K | 410K | 635K | ||||||
| Non-operating interest income | 70.00%697K | -3.78%611K | ---- | ---- | ---- | --410K | --635K | ---- | ---- | ---- |
| Other net income (expense) | 336.48%1.02M | -117.64%-400K | 525.35%2.71M | -14.38%-7.12M | -1,021.33%-8.78M | -90.74%233K | 165.08%2.27M | 109.70%434K | 92.35%-6.23M | 46.15%-783K |
| Gain on sale of security | 113.62%215K | -831.94%-1.93M | 168.55%1.17M | 70.69%-2.38M | 137.16%635K | -188.26%-1.58M | 107.06%263K | 62.07%-1.7M | -1,978.77%-8.13M | -16.58%-1.71M |
| Special income (charges) | ---- | ---- | ---- | ---13.5M | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | --13.5M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | -293.02%-83K | -4.88%39K | -27.49%1.55M | 360.43%8.76M | 832.61%8.64M | -94.09%43K | -82.77%41K | 19,309.09%2.14M | 102.35%1.9M | 7,616.67%926K |
| Income before tax | -3.35%-52.52M | -30.95%-55.46M | -15.22%-45.63M | -61.61%-198.41M | -66.32%-65.64M | -74.40%-50.82M | -42.18%-42.35M | -62.48%-39.6M | 25.98%-122.77M | 35.85%-39.47M |
| Income tax | 0 | -532.26%-134K | 166.34%134K | 70.57%-279K | 0 | -150.94%-108K | 107.01%31K | 62.03%-202K | -95.06%-948K | -113.47%-186K |
| Net income | -3.57%-52.52M | -30.53%-55.33M | -16.15%-45.76M | -62.64%-198.13M | -67.10%-65.64M | -72.77%-50.71M | -44.42%-42.39M | -65.26%-39.4M | 26.33%-121.82M | 37.56%-39.28M |
| Net income continuous Operations | -3.57%-52.52M | -30.53%-55.33M | -16.15%-45.76M | -62.64%-198.13M | -67.10%-65.64M | -72.77%-50.71M | -44.42%-42.39M | -65.26%-39.4M | 26.33%-121.82M | 37.56%-39.28M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -3.57%-52.52M | -30.53%-55.33M | -16.15%-45.76M | -62.64%-198.13M | -67.10%-65.64M | -72.77%-50.71M | -44.42%-42.39M | -65.26%-39.4M | 26.33%-121.82M | 37.56%-39.28M |
| Preferred stock dividends | 16.83%20.19M | -79.35%1.31M | ||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -3.57%-52.52M | -30.53%-55.33M | -16.15%-45.76M | -39.52%-198.13M | -61.69%-65.64M | -41.99%-50.71M | -18.92%-42.39M | -31.04%-39.4M | 22.87%-142.01M | 41.40%-40.6M |
| Basic earnings per share | 20.00%-0.44 | 2.13%-0.46 | 0.00%-0.44 | 47.97%-2.18 | -28.57%-0.72 | -45.29%-0.55 | 5.32%-0.47 | -5.08%-0.44 | -63.39%-4.19 | 41.96%-0.56 |
| Diluted earnings per share | 20.00%-0.44 | 2.13%-0.46 | 0.00%-0.44 | 47.97%-2.18 | -28.57%-0.72 | -45.29%-0.55 | 5.32%-0.47 | -5.08%-0.44 | -63.39%-4.19 | 41.96%-0.56 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.